MedTrace Logo

RNA Assays for Endometriosis Detection and Diagnosis

NCT06907303 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-04-02

No results posted yet for this study

Summary

Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is usually made after surgery. A key unmet need therefore is an accurate biomarker that can be used to detect the disease early. This study is a prospective trial to identify candidate mRNA-markers which can be used to aid in the diagnosis of this disease. It is a discovery/validation study that will identify and confirm a gene expression panel that is specific for endometriosis and provides a non-invasive tool for future use.

Conditions

  • Endometriosis

Interventions

DIAGNOSTIC_TEST

EndoDx

PCR assay for Endometriosis diagnosis

Sponsors & Collaborators

  • University of Cape Town

    collaborator OTHER

  • Wren Laboratories LLC

    lead INDUSTRY

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-08-31
Completion
2026-12-31

Countries

  • United States
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06907303 on ClinicalTrials.gov